The activation of OR4K17, a member of the olfactory receptor family, is intricately linked to the cAMP-dependent signaling pathway, a central cascade in the transduction of olfactory signals. Chemical activators that increase intracellular cAMP levels, such as adenylate cyclase activators, directly enhance the signaling of OR4K17. Inhibitors of phosphodiesterase, the enzyme responsible for cAMP degradation, also play a crucial role in sustaining the cAMP signaling, thereby indirectly supporting the functional activity of OR4K17. Moreover, the use of cAMP analogs that resist enzymatic degradation provides a robust method for sustaining OR4K17 activation. The modulation of intracellular cAMP concentrations is further complemented by the action of histone deacetylase inhibitors, which facilitate a transcriptionally active chromatin state and indirectly lead to the increased expression of the OR4K17 receptor.
Allosteric modulators, such as zinc sulfate, can favorably alter the receptor conformation of OR4K17, thus promoting its activity. Additionally, odorant molecules, which include a variety of aldehydes, ketones, and esters, are direct agonists that activate OR4K17 through specific ligand-receptor interactions, which constitute the primary mechanism of action for olfactory receptors. Other compounds that act on different receptors, such as nicotinic acetylcholine receptors, influence the cAMP pathway and, as a result, may enhance OR4K17 signaling indirectly. The involvement of cofactors in enzymatic reactions within the cAMP pathway, such as magnesium sulfate, is also critical as they optimize these biochemical processes, potentially leading to increased OR4K17 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents the breakdown of cAMP, thereby sustaining the activation of cAMP-dependent pathways that are known to be crucial for the function of OR4K17. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that is resistant to degradation by phosphodiesterases, directly enhancing the cAMP signaling cascade, which is a key modulator of OR4K17 activity. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Phosphodiesterase inhibitor that leads to an accumulation of cAMP, indirectly supporting the activity of OR4K17 through sustained cAMP signaling. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Functions as an allosteric modulator of olfactory receptors and may promote OR4K17 activity by stabilizing receptor conformation that is favorable for activation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Phosphodiesterase inhibitor that can increase intracellular cAMP levels, which are essential for the activation of OR4K17 through the cAMP signaling pathway. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can lead to a chromatin state favoring transcriptional activation, thereby indirectly increasing the expression of OR4K17. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase-4 inhibitor that raises cAMP levels, potentially promoting OR4K17 activation through the cAMP-dependent signaling pathway. | ||||||
Magnesium sulfate anhydrous | 7487-88-9 | sc-211764 sc-211764A sc-211764B sc-211764C sc-211764D | 500 g 1 kg 2.5 kg 5 kg 10 kg | $46.00 $69.00 $163.00 $245.00 $418.00 | 3 | |
Cofactor for many enzymes, including those involved in the cAMP pathway, possibly enhancing OR4K17 signaling by optimizing the enzymatic reactions within this pathway. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Acts on adenosine receptors, which can influence cAMP production, potentially leading to increased OR4K17 activity via the cAMP signaling pathway. | ||||||